KalVista Pharmaceuticals, Inc. (KALV)
16.23
+0.02
(+0.12%)
USD |
NASDAQ |
Mar 06, 16:00
16.31
+0.08
(+0.49%)
After-Hours: 20:00
KalVista Pharmaceuticals Total Liabilities (Quarterly) : 322.93M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 170.73M |
| Recursion Pharmaceuticals, Inc. | 397.49M |
| Tango Therapeutics, Inc. | 63.83M |
| Modular Medical, Inc. | 4.378M |
| Iovance Biotherapeutics, Inc. | 214.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 339.93M |
| Shareholders Equity (Quarterly) | 17.00M |
| Debt to Equity Ratio | 16.62 |
| Current Ratio | 7.216 |
| Net Debt Paydown Yield | -8.98% |